Schizophrenia/Psychosis

Which genes have recently been associated with TD? That question and more in this quiz.

New evidence bolsters the reputation of clozapine as the “gold-standard” antipsychotic for patients with treatment-resistant schizophrenia.

Tips for having a balanced and comprehensive risk-to-benefit discussion with competent patients who want to stop their medications.

Is an effective, well-tolerated treatment for the negative symptoms of schizophrenia on the horizon?

No, there is no generalized epidemic of mental illness in the US, nor credible evidence that psychiatric drugs are driving up rates or severity of mental illness. But there is an urgent need for more and better treatment of psychiatric disorders.

What factors come into play in the diagnosis of tardive dyskinesia? How is TD distinguished from other movement disorders? Find out more in this quiz.

This article focuses on appropriate versus inappropriate use of antipsychotics, the importance of careful assessment, and the consequences of not treating.

Schizophrenia and T2 DM risk; short-term weight gain with specific antipsychotics; interventions to reduce weight and/or metabolic abnormalities. . .answers here.

Six fundamental assumptions underlie the medical model most psychiatrists use in their clinical work.

New findings support the involvement of microbiota alterations in psychosis-and point to novel treatments.

Which psychotropic combinations unlock the door to successful treatment?

Do prolactin-elevating antipsychotics put women at risk for endometrial cancer?

Which gene is not associated with risk for the development of TD? What is the prevalence of TD in patients with schizophrenia treated with antipsychotics? Those questions and more in this quiz.

The authors compare the clinical features of idiopathic psychosis (eg, schizophrenia) with cannabis-induced psychosis.

A novel neuromodulatory intervention for an often-overlooked but nonetheless damaging effect of schizophrenia.

Brian Miller joins the Editorial Board of Psychiatric Times.

Numerous lines of evidence suggest a correlation between cannabis consumption and a variety of psychiatric conditions, including cannabis-induced psychosis.

Which of these agents best prevents relapse? A recent study employed a novel approach to find out.

How widely used is this “gold-standard” antipsychotic?

We have criminalized mental health problems-a barbaric throwback to the dismal conditions before the Enlightenment.

Have antipsychotic and placebo responses in acute schizophrenia changed over time?

Here's why psychiatrists and other mental health professionals need to understand the relationship between cannabis and mental disorders.

Because patients who have psychiatric illnesses typically receive less frequent medical care, psychiatrists must aim to ensure appropriate monitoring of metabolic parameters when antipsychotic medications are used.

We’ve been waiting since 1953, the year chlorpromazine was introduced to the US as a revolutionary treatment for schizophrenia, for an active treatment for tardive dyskinesia that the FDA judged to be effective.

How does a pituitary result in a psychiatric emergency? Read more clues to this clinical puzzle.